Cabergoline, an ergot derivative, is a long-acting dopamine agonist and prolactin inhibitor
4
Cabergoline is a prescription medication used to treat hyperprolactinemia (high levels of prolactin)
Objectives: Identify the mechanism of action of dopamine agonists
Cabergoline is a synthetic ergoline dopamine agonist with a high affinity for dopamine D2 receptors and a long elimination half-life
bethanechol
The effect of formulation on the urinary pharmacokinetics, pharmacodynamics, and relative bioavailability of cabergoline was investigated
It not only suppresses hormone production from these prolactinomas, but also causes tumour shrinkage
Cabergoline: It is a long-acting dopamine agonist and also an inhibitor of prolactin
1N hydrochloric acid; very slightly soluble in n-hexane; and insoluble in water
Metformin, a biguanide widely used in the treatment of diabetes mellitus, has been shown to reduce prolactin secretion in various pituitary tumor-cell lineages both in vitro and in vivo and in human pituitary adenomas in
Cabergoline decreased serum prolactin levels in reserpinized rats
Cabergoline is a long acting dopamine receptor agonist with a high affinity for D2 receptors
26) and 1
1-6-Allilergolin-8beta-ylcarbonyl-1-3-dimethylaminepropyl-3-ethylurea
Indications Dog cabergoline decreases effects of glyceryl trinitrate pr by pharmacodynamic antagonism
Contraindicated
These data suggest that cabergoline acts on processes induced by exposure to ethanol rather than on general rewarding and/or motivational mechanisms
The
62
Nine patients on steroidogenesis inhibitors received cabergoline add-on therapy for 19 months (1-240)
Neuroprotection is the primary concern in patients with newly diagnosed Parkinson’s disease
Cabergoline decreased serum prolactin levels in reserpinized rats
However, cabergoline is not associated with the development of new onset delusions or hallucinations